Engineers Gate Manager’s Acceleron Pharma XLRN Stock Holding History

Engineers Gate Manager’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,357	Closed	-$1.05M	–	2128
2021 Q2	$1.05M	Buy	+8,357	New	+$1.05M	0.07%	414
2021 Q1	–	Sell	-2,281	Closed	-$292K	–	2223
2020 Q4	$292K	Buy	+2,281	New	+$267K	0.01%	1309
2020 Q1	–	Sell	-7,642	Closed	-$405K	–	2066
2019 Q4	$405K	Buy	+7,642	New	+$348K	0.02%	1102
2019 Q3	–	Sell	-9,220	Closed	-$379K	–	1696
2019 Q2	$379K	Buy	+9,220	New	+$382K	0.02%	807

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Engineers Gate Manager's XLRN Position: Q3 2021 in Review

Engineers Gate Manager sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 8,357 shares — an estimated $1.05M sold.

Engineers Gate Manager first reported a position in XLRN in Q2 2019 and held it in 4 quarters. The position peaked at $1.05M in Q2 2021. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

Engineers Gate Manager reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
Engineers Gate Manager sold 8,357 Acceleron Pharma shares in Q3 2021, an estimated $1.05M.
Engineers Gate Manager first reported a position in Acceleron Pharma in Q2 2019 and held it in 4 quarters.
Engineers Gate Manager's Acceleron Pharma position peaked at $1.05M in Q2 2021.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on Engineers Gate Manager's 13F filing for Q3 2021, filed 15 Nov 2021.